- Home
- NIVF vs MTNB Comparison
NIVF vs MTNB Comparison
Compare NIVF & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIVF
- MTNB
- Stock Information
- Founded
- NIVF 2011
- MTNB 2013
- Country
- NIVF Hong Kong
- MTNB United States
- Employees
- NIVF N/A
- MTNB N/A
- Industry
- NIVF
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- NIVF
- MTNB Health Care
- Exchange
- NIVF NYSE
- MTNB Nasdaq
- Market Cap
- NIVF 3.9M
- MTNB 3.1M
- IPO Year
- NIVF N/A
- MTNB N/A
- Fundamental
- Price
- NIVF $0.71
- MTNB $0.55
- Analyst Decision
- NIVF
- MTNB Hold
- Analyst Count
- NIVF 0
- MTNB 1
- Target Price
- NIVF N/A
- MTNB N/A
- AVG Volume (30 Days)
- NIVF 357.8K
- MTNB 29.1K
- Earning Date
- NIVF 01-01-0001
- MTNB 05-08-2025
- Dividend Yield
- NIVF N/A
- MTNB N/A
- EPS Growth
- NIVF N/A
- MTNB N/A
- EPS
- NIVF N/A
- MTNB N/A
- Revenue
- NIVF $5,679,218.00
- MTNB N/A
- Revenue This Year
- NIVF N/A
- MTNB N/A
- Revenue Next Year
- NIVF N/A
- MTNB N/A
- P/E Ratio
- NIVF N/A
- MTNB N/A
- Revenue Growth
- NIVF N/A
- MTNB N/A
- 52 Week Low
- NIVF $0.11
- MTNB $0.48
- 52 Week High
- NIVF $9.15
- MTNB $18.10
- Technical
- Relative Strength Index (RSI)
- NIVF 54.67
- MTNB 48.96
- Support Level
- NIVF $0.56
- MTNB $0.52
- Resistance Level
- NIVF $0.77
- MTNB $0.58
- Average True Range (ATR)
- NIVF 0.15
- MTNB 0.05
- MACD
- NIVF -0.01
- MTNB 0.00
- Stochastic Oscillator
- NIVF 75.99
- MTNB 48.50
About NIVF NEWGENIVF GROUP LIMITED
NewGenIvf Group Ltd is a company engaged in providing assisted reproductive services in Asia Pacific with a focus on providing fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely first which is a in-vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and surrogacy and ancillary caring services.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.